EYE5:Volunteer Assignments and Opportunities - Revision history

Jennelleh at 18:54, 10 September 2024

2024-09-10T18:54:48Z

← Older revision		Revision as of 13:54, 10 September 2024
Line 19:		Line 19:
	!'''Notes'''		!'''Notes'''
	\|-		\|-
	\|CHAPTER 2 (TUMOURS OF THE CONJUCTIVA AND CARUNCLE)		\|
			==== CHAPTER 2 (TUMOURS OF THE CONJUCTIVA AND CARUNCLE) ====
	\|		\|
	----		----
Line 259:		Line 260:
	\|		\|
	\|-		\|-
	\|CHAPTER 3 (TUMOURS OF THE EYELID)		\|
			==== CHAPTER 3 (TUMOURS OF THE EYELID) ====
	\|		\|
	----		----
Line 620:		Line 622:
	\|		\|
	\|-		\|-
	\|CHAPTER 4 (TUMOURS OF THE UVEAL TRACT)		\|
			==== CHAPTER 4 (TUMOURS OF THE UVEAL TRACT) ====
	\|		\|
	----		----
Line 761:		Line 764:
	\|		\|
	\|-		\|-
	\|CHAPTER 5 (TUMOURS OF THE RETINA AND NEUROEPITHELIUM)		\|
			==== CHAPTER 5 (TUMOURS OF THE RETINA AND NEUROEPITHELIUM) ====
	\|		\|
	----		----
Line 924:		Line 928:
	\|		\|
	\|-		\|-
	\|CHAPTER 6 (TUMOURS OF THE OPTIC DISC AND OPTIC NERVE)		\|
			==== CHAPTER 6 (TUMOURS OF THE OPTIC DISC AND OPTIC NERVE) ====
	\|		\|
	----		----
Line 999:		Line 1,004:
	\|		\|
	\|-		\|-
	\|CHAPTER 7 (TUMOURS OF THE LACRIMAL GLAND)		\|
			==== CHAPTER 7 (TUMOURS OF THE LACRIMAL GLAND) ====
	\|		\|
	----		----
Line 1,162:		Line 1,168:
	\|		\|
	\|-		\|-
	\|CHAPTER 8 (TUMOURS OF THE LACRIMAL DRAINAGE SYSTEM)		\|
			==== CHAPTER 8 (TUMOURS OF THE LACRIMAL DRAINAGE SYSTEM) ====
	\|		\|
	----		----
Line 1,259:		Line 1,266:
	\|		\|
	\|-		\|-
	\|CHAPTER 9 (TUMOURS OF THE ORBIT)		\|
			==== CHAPTER 9 (TUMOURS OF THE ORBIT) ====
	\|		\|
	----		----
Line 1,389:		Line 1,397:
	\|		\|
	\|-		\|-
	\|CHAPTER 10 (HAEMATOLYMPHOID TUMOURS)		\|
			==== CHAPTER 10 (HAEMATOLYMPHOID TUMOURS) ====
	\|		\|
	----		----
Line 1,629:		Line 1,638:
	\|		\|
	\|-		\|-
	\|CHAPTER 11 (SOFT TISSUE AND BONE TUMOURS)		\|
			==== CHAPTER 11 (SOFT TISSUE AND BONE TUMOURS) ====
	\|		\|
	----		----
Line 2,122:		Line 2,132:
	\|		\|
	\|-		\|-
	\|CHAPTER 12 (METASTASES TO THE EYE AND SURROUNDING STRUCTURES)		\|
			==== CHAPTER 12 (METASTASES TO THE EYE AND SURROUNDING STRUCTURES) ====
	\|		\|
	----		----
Line 2,164:		Line 2,175:
	\|		\|
	\|-		\|-
	\|CHAPTER 13 (GENETIC TUMOUR SYNDROMES)		\|
			==== CHAPTER 13 (GENETIC TUMOUR SYNDROMES) ====
	\|		\|
	----		----

Jennelleh at 18:53, 10 September 2024

2024-09-10T18:53:37Z

← Older revision		Revision as of 13:53, 10 September 2024
Line 6:		Line 6:

	To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.		To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
			__TOC__
	<br />		<br />
	{\| class="wikitable" style="margin:auto"		{\| class="wikitable" style="margin:auto"

Jennelleh at 19:10, 12 July 2024

2024-07-12T19:10:34Z

← Older revision		Revision as of 14:10, 12 July 2024
Line 2,208:		Line 2,208:
	\|[[EYE5:Von_Hippel_Lindau_syndrome\|Von Hippel Lindau syndrome]]		\|[[EYE5:Von_Hippel_Lindau_syndrome\|Von Hippel Lindau syndrome]]
	\|Disease		\|Disease
	\|		\|[[GTS5:Volunteer Assignments and Opportunities\|See GTS5 volunteer sheet for authorship status]]
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|-		\|-
	\|[[EYE5:Sturge_Weber_syndrome\|Sturge Weber syndrome]]		\|[[EYE5:Sturge_Weber_syndrome\|Sturge Weber syndrome]]

Jennelleh at 18:41, 12 July 2024

2024-07-12T18:41:45Z

← Older revision		Revision as of 13:41, 12 July 2024
Line 2,230:		Line 2,230:
	\|[[EYE5:Neurofibromatosis_type_1_(NF1)\|Neurofibromatosis type 1 (NF1)]]		\|[[EYE5:Neurofibromatosis_type_1_(NF1)\|Neurofibromatosis type 1 (NF1)]]
	\|Disease		\|Disease
	\|		\|[[GTS5:Volunteer Assignments and Opportunities\|See GTS5 volunteer sheet for authorship status]]
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|-		\|-
	\|[[EYE5:Goldenhar_syndrome\|Goldenhar syndrome]]		\|[[EYE5:Goldenhar_syndrome\|Goldenhar syndrome]]

Jennelleh at 21:13, 26 January 2024

2024-01-26T21:13:19Z

Show changes

Jennelleh at 03:28, 25 December 2023

2023-12-25T03:28:08Z

← Older revision		Revision as of 22:28, 24 December 2023
Line 18:		Line 18:
	!'''Date of Last Editor Review'''		!'''Date of Last Editor Review'''
	!'''Notes'''		!'''Notes'''
	\|- ~~\|Usual ductal hyperplasia\|\|Disease\|\|~~		\|-
	\|
	~~\|Disease~~
	\|
	\|
	\|
	\|
	\|
	\|-		\|-
	\| \|\|Disease\|\|		\| \|\|Disease\|\|

Jennelleh at 18:02, 24 December 2023

2023-12-24T18:02:05Z

Show changes

Jennelleh: Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo..."

2023-12-24T18:01:30Z

Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo..."

New page

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please '''[[Mailto:CCGA@cancergenomics.org Contact us]]''' with your page of interest.

 
{| class="wikitable" style="margin:auto"
|+<big>WHO Classification of Eye and Orbit Tumours (5th Edition) Content</big>
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|- |Usual ductal hyperplasia||Disease||
|Usual Ductal Hyperplasia
|Disease
|
|
|
|
|
|-
|Columnar Cell Lesions, Including Flat Epithelial Atypia||Disease||
|
|
|
|
|
|
|
|-
|Atypical Ductal Hyperplasia||Disease||
|
|
|
|
|
|
|
|-
|Sclerosing Adenosis||Disease||
|
|
|
|
|
|
|
|-
|Apocrine Adenosis and Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Microglandular Adenosis||Disease||
|
|
|
|
|
|
|
|-
|Radial Scar/Complex Sclerosing Lesion||Disease||
|
|
|
|
|
|
|
|-
|Tubular Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Lactating Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Ductal Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Pleomorphic Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Adenomyoepithelioma||Disease||
|
|
|
|
|
|
|
|-
|Malignant Adenomyoepithelioma||Disease||
|
|
|
|
|
|
|
|-
|Intraductal Papilloma||Disease||
|
|
|
|
|
|
|
|-
|Papillary Ductal Carcinoma In Situ||Disease||
|
|
|
|
|
|
|
|-
|Encapsulated Papillary Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Solid Papillary Carcinoma (In Situ and Invasive)||Disease||
|
|
|
|
|
|
|
|-
|Invasive Papillary Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Atypical Lobular Hyperplasia||Disease||
|
|
|
|
|
|
|
|-
|Lobular Carcinoma In Situ||Disease||
|
|
|
|
|
|
|
|-
|Ductal Carcinoma In Situ||Disease||
|
|
|
|
|
|
|
|-
|Invasive Breast Carcinoma of No Special Type||Disease||
|
|
|
|
|
|
|
|-
|Microinvasive Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Invasive lobular Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Tubular Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Cribriform Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Mucinous Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Mucinous Cystadenocarcinoma||Disease||
|
|
|
|
|
|
|
|-
|Invasive Micropapillary Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Carcinoma with Apocrine Differentiation||Disease||
|
|
|
|
|
|
|
|-
|Metaplastic Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Acinic Cell Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Adenoid Cystic Carcinoma||Disease||Katherine Geiersbach / Jun Liao
|10/12/02022
|11/11/2023
|COMPLETE
|
|Hui Chen / Katherine Geiersbach
|12/6/2023
|2021 template added
|-
|Secretory Carcinoma||Disease||Hui Chen / Morteza Seifi
|10/12/2022
|11/11/2023
|PENDING
|
|Katherine Geiersbach
|
|2021 template added
|-
|Mucoepidermoid Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Polymorphous Adenocarcinoma||Disease||
|
|
|
|
|
|
|
|-
|Tall Cell Carcinoma with Reversed Polarity||Disease||H. Evin Gulbahce
|8/11/2023
|10/11/2023
|COMPLETE
|
|Katherine Geiersbach
|
|2021 template added
|-
|Neuroendocrine Tumour||Disease||
|
|
|
|
|
|
|
|-
|Neuroendocrine Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Hamartoma||Disease||
|
|
|
|
|
|
|
|-
|Fibroadenoma||Disease||H. Evin Gulbahce / Patricija Zot
|8/11/2023
|11/11/2023
|PENDING
|
|
|
|2021 template added
|-
|Phyllodes Tumour||Disease||H. Evin Gulbahce / Patricija Zot / Emilie Lalonde / Katherine Geiersbach
|8/11/2023
|11/11/2023
|PENDING
|
|
|
|2021 template added
|-
|Syringomatous Tumour||Disease||
|
|
|
|
|
|
|
|-
|Nipple Adenoma||Disease||
|
|
|
|
|
|
|
|-
|Paget disease of the Breast||Disease||
|
|
|
|
|
|
|
|-
|Haemangioma||Disease||
|
|
|
|
|
|
|
|-
|Angiomatosis||Disease||
|
|
|
|
|
|
|
|-
|Atypical Vascular Lesions||Disease||
|
|
|
|
|
|
|
|-
|Postradiation Angiosarcoma of the Breast||Disease||
|
|
|
|
|
|
|
|-
|Primary Angiosarcoma of the Breast||Disease||
|
|
|
|
|
|
|
|-
|Nodular Fasciitis||Disease||
|
|
|
|
|
|
|
|-
|Myofibroblastoma||Disease||
|
|
|
|
|
|
|
|-
|Desmoid Fibromatosis||Disease||
|
|
|
|
|
|
|
|-
|Inflammatory Myofibroblastic Tumour||Disease||Yajuan Liu
|8/11/2023
|11/11/2023
|COMPLETE
|
|Katherine Geiersbach
|12/6/2023
|2021 template added
|-
|Schwannoma||Disease||
|
|
|
|
|
|
|
|-
|Neurofibroma||Disease||
|
|
|
|
|
|
|
|-
|Granular Cell Tumour||Disease||
|
|
|
|
|
|
|
|-
|Leiomyoma||Disease||
|
|
|
|
|
|
|
|-
|Leiomyosarcoma||Disease||
|
|
|
|
|
|
|
|-
|Lipoma||Disease||
|
|
|
|
|
|
|
|-
|Angiolipoma||Disease||
|
|
|
|
|
|
|
|-
|Liposarcoma||Disease||
|
|
|
|
|
|
|
|-
|Pseudoangiomatous Stromal Hyperplasia||Disease||
|
|
|
|
|
|
|
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||
|
|
|
|
|
|
|
|-
|Follicular Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Diffuse Large B-cell Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Burkitt Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||
|
|
|
|
|
|
|
|-
|Gynaecomastia||Disease||
|
|
|
|
|
|
|
|-
|Carcinoma In Situ||Disease||
|
|
|
|
|
|
|
|-
|Invasive Carcinoma||Disease||
|
|
|
|
|
|
|
|-
|Metastases to the Breast||Disease||
|
|
|
|
|
|
|
|-
|BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease||Constance Albarracin / Katherine Geiersbach
|12/6/2023
|3/6/2024
|
|
|
|
|
|-
|Cowden Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Ataxia-Telangiectasia||Disease||Evin Gulbahce / Katherine Geiersbach
|12/11/2023
|3/11/2024
|
|
|Katherine Geiersbach
|
|
|-
|Li-Fraumeni Syndrome, TP53-Associated||Disease||
|
|
|
|
|
|
|
|-
|Li-Fraumeni Syndrome, CHEK2-Associated||Disease||
|
|
|
|
|
|
|
|-
|CDH1-Associated Breast Cancer||Disease||
|
|
|
|
|
|
|
|-
|PALB2-Associated Cancers||Disease||Constance Albarracin / Katherine Geiersbach
|12/8/2023
|3/8/2024
|
|
|
|
|
|-
|Peutz-Jeghers Syndrome||Disease||
|
|
|
|
|
|
|
|-
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
|
|
|
|
|
|
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Polygenic Component of Breast Cancer Susceptibility
|Disease
|
|
|
|
|
|
|
|
|-
|}